- Record: found
- Abstract: found
- Article: not found
Budesonide 9 mg is at least as effective as mesalamine 4.5 g in patients with mildly to moderately active Crohn's disease.
Andreas Tromm
1 ,
Ivan Bunganič ,
Eva Tomsová ,
Zsolt Tulassay ,
Milan Lukáš ,
Jan Kykal ,
Marian Bátovský ,
Bohumil Fixa ,
Libor Gabalec ,
Rifaat Safadi ,
Heinz-Jochen Kramm ,
István Altorjay ,
Hanns Löhr ,
Ioannis Koutroubakis ,
Simon Bar-Meir ,
Davor Stimac ,
Elke Schäffeler ,
Christoph Glasmacher ,
Karin Dilger ,
Ralf Mohrbacher ,
Roland Greinwald
Feb 2011
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Comparative data on budesonide vs mesalamine for the treatment of mild-to-moderately active Crohn's disease (CD) are sparse. We assessed the efficacy and safety of each therapy in patients with mildly to moderately active CD.